MRM Health NV announced that it has received 14,250,000 in an equity round of funding on February 19, 2020. The transaction will include participation from new investor DuPont Nutrition & Biosciences through DuPont de Nemours, Inc., Qbic II, a fund managed by QBIC Venture Partners, and VIB BV., and returning investors, Ackermans & Van Haaren NV for 4,000,000 and more than 15% stake, and MRM Technologies.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
79.48 USD | +1.21% | +9.61% | +3.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.30% | 32.83B | |
-0.24% | 77.64B | |
+2.67% | 47.58B | |
+8.66% | 17.99B | |
-8.29% | 11.81B | |
+12.36% | 11.61B | |
+1.46% | 10.35B | |
+6.35% | 9.91B | |
-2.65% | 9.2B | |
+4.42% | 8.32B |
- Stock Market
- Equities
- DD Stock
- News DuPont de Nemours, Inc.
- MRM Health NV announced that it has received €14.25 million in funding from DuPont de Nemours, Inc., Ackermans & Van Haaren NV, VIB BV, QBIC Venture Partners, MRM Technologies N.V.